ASEAN Non-Invasive Neurostimulation Devices Market Outlook (2026-2033)
Description
The ASEAN non-invasive neurostimulation devices market is forecast to expand from US$ 17.2 million in 2025 to US$ 44.1 million by 2033. The market is projected to grow at a CAGR of 12.5% between 2026 and 2033.
Across ASEAN countries, demand for non-invasive neurostimulation devices is increasing as therapies such as transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), and emerging wearable brain-modulation technologies gain greater clinical attention. Healthcare professionals are increasingly considering these approaches for conditions such as epilepsy, depression, and post-stroke impairments because they can complement conventional pharmaceutical treatment while potentially reducing medication-related side effects.
Investment in rehabilitation infrastructure is also creating favorable conditions for market development. Hospitals are increasingly integrating digital healthcare technologies that enable remote patient monitoring, follow-up consultations, and more individualized treatment programs. At the same time, regulatory differences between ASEAN countries and limited reimbursement coverage in several markets continue to restrict widespread adoption. Consequently, advanced neurostimulation technologies remain concentrated primarily in large urban hospitals and specialized healthcare facilities.
Manufacturers are responding to changing clinical requirements by developing smaller, lighter, and more portable systems. These developments are attracting interest from outpatient centers, specialist clinics, and dedicated mental health facilities that require greater flexibility in treatment delivery. As a result, assessment and utilization of neurostimulation technologies are expanding across several major ASEAN economies.
Nevertheless, market adoption continues to face challenges related to limited clinician familiarity with advanced neuromodulation protocols. Specialized training is often required for device calibration, patient selection, and treatment planning, while hospitals tend to follow cautious procurement strategies. This is particularly relevant in cost-sensitive public healthcare systems, where purchasing decisions generally prioritize technologies with established clinical outcomes and clear economic value.
Awareness among patients is also improving, particularly in urban centers. Greater exposure to digital mental health services, combined with physician-led education programs in tertiary healthcare networks, is increasing familiarity with non-invasive brain stimulation. Consequently, adjunctive neuromodulation therapies are gradually becoming more accepted within clinical practice across the region.
The ASEAN non-invasive neurostimulation devices market is analyzed based on product type, application, and end user.
Market Segmentation by Product Type
By product type, the market is categorized into transcranial magnetic stimulation devices, transcranial direct current stimulation devices, transcranial ultrasound stimulation devices, and other product types. Transcranial magnetic stimulation devices accounted for the largest share of the market in 2025, supported by their established clinical applications and growing adoption across neurological and psychiatric care.
Market Segmentation by Application
On the basis of application, the market is divided into pain & sensory modulation, functional disorders, cognitive & behavioral regulation, and other applications. Cognitive & behavioral regulation was the leading application segment in 2025, driven by increasing demand for neurostimulation-based approaches in mental health and cognitive-related care.
Market Segmentation by End User
In terms of end user, the market is segmented into hospitals, specialty clinics, ambulatory surgical centers, and other end users. Hospitals held the dominant position in 2025, supported by their access to advanced medical equipment, trained professionals, and a larger pool of patients requiring specialized neurological treatment.
Investment in Neuroscience Research
Non-invasive neurostimulation technologies are increasingly being incorporated into neuroscience research programs across ASEAN. Universities, teaching hospitals, and clinical engineering laboratories are using these systems to investigate brain function and evaluate potential therapeutic applications.
Device manufacturers are increasingly collaborating with academic institutions to refine technology according to regional clinical requirements. These partnerships support prototype development, device testing, and optimization of treatment approaches. Researchers can provide practical feedback that helps manufacturers improve system performance and adapt technologies to local patient and clinical needs.
Hospitals in Southeast Asia are also entering into longer-term evaluation arrangements to assess neurostimulation technologies before committing to broader deployment. Rather than immediately implementing these systems on a large scale, healthcare providers are placing greater emphasis on feedback from physicians and clinical teams. This approach allows manufacturers to identify software limitations, improve user interfaces, and modify device functionality according to real-world requirements.
Growing clinician participation is also influencing research investment priorities. Studies increasingly examine how effectively neurostimulation devices can be integrated into existing rehabilitation and treatment workflows, rather than focusing solely on theoretical technical capabilities. Collaboration between engineers, neurologists, rehabilitation specialists, and other healthcare professionals is helping ensure that device development reflects practical care requirements.
As a result, neurostimulation technologies within ASEAN healthcare facilities are increasingly evolving alongside clinical treatment models, creating a closer connection between medical device innovation and patient-care processes.
Use in Addiction Treatment Therapies
Non-invasive neurostimulation is beginning to attract interest within addiction treatment programs across ASEAN, where it is being explored as an additional component of behavioral and rehabilitation therapies. Rather than depending exclusively on pharmacological approaches, clinicians are investigating stimulation techniques that may influence neural pathways associated with craving management, impulse control, and behavioral regulation.
Urban outpatient clinics are experimenting with structured stimulation sessions that can be coordinated with counseling and behavioral therapy schedules. Such protocol-based approaches are intended to improve treatment participation and encourage continued engagement throughout the recovery process.
The region is also moving toward integrated addiction-care models in which neurostimulation serves as a complementary intervention rather than an independent therapy. Rehabilitation professionals are incorporating stimulation into broader recovery programs that may include counseling, behavioral interventions, and other supportive services.
As these approaches develop, training programs for counselors and clinical staff are increasingly incorporating basic device operation, patient monitoring, and response assessment. This can help community clinics and hospitals safely incorporate neurostimulation into multidisciplinary addiction treatment programs.
Patient experience is also influencing the development of neurostimulation equipment for addiction care. Manufacturers are placing greater emphasis on comfortable device designs, simple interfaces, and easier operation to minimize treatment fatigue. Consistent stimulation schedules may help patients remain engaged with counseling programs and reduce early treatment discontinuation.
These trends are encouraging pilot projects and collaborative treatment networks throughout the region, supporting further investigation of neurostimulation as part of coordinated addiction recovery programs.
The ASEAN non-invasive neurostimulation devices market is demonstrating strong growth, with market size and share analysis reflecting changing healthcare requirements, technology adoption patterns, and competitive developments. The report evaluates key market subsegments across product type, application, and end user and assesses their contribution to overall market performance.
Transcranial magnetic stimulation devices represented the largest product type segment in 2025. Their leadership was supported by established clinical effectiveness, expanding use in neurological and psychiatric disorders, and greater availability across healthcare facilities.
Cognitive & behavioral regulation accounted for the largest application share in 2025. Growth in this segment is associated with increasing mental health concerns and the expanding use of neurostimulation for depression, anxiety, and cognitive enhancement.
Hospitals were the leading end-user segment in 2025, supported by their access to advanced neurostimulation technologies, qualified medical professionals, and growing numbers of patients requiring specialized neurological services.
Scope of the ASEAN Market Report
The ASEAN Non-Invasive Neurostimulation Devices Market Size and Forecast (2022–2033) report provides a comprehensive evaluation of the market and covers the following areas:
Market segments included within the study
Market dynamics, including drivers, restraints, opportunities, and emerging trends
Market concentration and heat map analysis
Leading companies and recent developments
Detailed company profiles
SWOT analysis of key market participants
The geographical scope of the ASEAN non-invasive neurostimulation devices market covers Indonesia, Malaysia, the Philippines, Singapore, Thailand, and Vietnam. Indonesia accounted for the largest market share in 2025.
Country-Level Market Analysis
Indonesia leads the ASEAN non-invasive neurostimulation devices market, supported by its large population base, increasing prevalence of neurological and psychiatric conditions, expanding urban hospital infrastructure, and rising private healthcare investment. These factors are contributing to greater adoption of advanced technologies for neurorehabilitation and pain management.
Malaysia is experiencing steady market development due to its advanced hospital infrastructure and increasing availability of neuromodulation therapies within specialist clinics. Its healthcare system is also gradually adopting innovative treatment approaches for chronic pain and mood-related disorders.
The Philippines represents a growing opportunity because of its significant need for improved neurological healthcare services and geographical characteristics that can increase the value of portable treatment technologies. Rising healthcare expenditure in urban areas, supported in part by the expansion of the middle class, is also encouraging investment in specialized medical services.
Singapore is one of the region's most advanced markets for healthcare innovation. Strong biomedical research capabilities, participation in clinical trials, sophisticated healthcare infrastructure, and a technology-oriented healthcare environment have enabled the country to integrate neurotechnology into clinical practice relatively quickly.
Thailand benefits from its well-established medical tourism industry and continued development of rehabilitation services for stroke and spinal conditions. Public healthcare programs addressing the needs of an aging population are also contributing to demand for neurological and rehabilitation technologies.
Vietnam is emerging as a rapidly developing market as healthcare infrastructure is modernized, private hospital networks expand, and awareness of non-invasive brain stimulation increases. However, treatment affordability remains an important consideration, while insurance coverage for newer technologies is developing gradually.
Overall, adoption rates vary across ASEAN according to healthcare infrastructure, clinical expertise, reimbursement availability, and affordability in both public and private healthcare settings. Digital health solutions and cross-border collaboration can improve access to advanced medical technologies while supporting clinician training and knowledge exchange.
Greater regulatory alignment across ASEAN could further encourage private investment and simplify the introduction of new neurostimulation technologies. Over time, these developments may accelerate adoption across hospitals, rehabilitation facilities, specialist clinics, and other healthcare environments.
Report Structureand Coverage
The report provides qualitative and quantitative analysis of the ASEAN non-invasive neurostimulation devices market across product type, application, end user, and geography. Chapter 2 presents the key findings, major trends, and market outlook for the ASEAN region. Chapter 3 explains the research methodology, while Chapter 4 provides an ecosystem analysis.
Chapter 5 examines the major industry dynamics, including market drivers, restraints, opportunities, and emerging trends. It also assesses the potential impact of these factors on market growth. Chapter 6 evaluates historical market revenues and provides forecasts through 2033.
Chapters 7 through 10 analyze the ASEAN market according to product type, application, end user, and geography. Geographic coverage includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, and Vietnam. These chapters provide market revenue assessments, forecasts, and an analysis of the factors influencing market development.
Chapter 11 presents competitive analysis and heat map analysis of key companies operating in the market. Chapter 12 examines the industry landscape, including strategic initiatives, new product or business developments, mergers, joint ventures, and other competitive activities.
Chapter 13 provides detailed profiles of major companies operating in the ASEAN market. These profiles cover company information, business descriptions, product portfolios, financial overviews, SWOT analysis, and significant developments. Chapter 14 serves as the appendix and includes a brief company overview, abbreviations, and relevant disclaimers.
Research Methodologyand Recent Developments
The ASEAN non-invasive neurostimulation devices market has been assessed using qualitative and quantitative information obtained through primary and secondary research. The study incorporates information from corporate publications, industry associations, specialized databases, company reports, investor presentations, and other relevant sources.
Several notable developments have contributed to the evolution of the regional market:
In August 2023, BrainsWay Ltd. announced an expansion in the availability of its Deep TMS non-invasive brain stimulation systems in Taiwan through additional installations. The initiative strengthened the company's presence in the broader Asia Pacific region and supported access to neuropsychiatric care technologies.
In February 2023, Nexstim Plc announced that it had received an order from Hong Kong through distributor Ampere Medical for its NBS 5 navigated transcranial magnetic stimulation (nTMS) system. The system supports neuroscience research and brain-mapping applications using non-invasive neurostimulation technology.
Across ASEAN countries, demand for non-invasive neurostimulation devices is increasing as therapies such as transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), and emerging wearable brain-modulation technologies gain greater clinical attention. Healthcare professionals are increasingly considering these approaches for conditions such as epilepsy, depression, and post-stroke impairments because they can complement conventional pharmaceutical treatment while potentially reducing medication-related side effects.
Investment in rehabilitation infrastructure is also creating favorable conditions for market development. Hospitals are increasingly integrating digital healthcare technologies that enable remote patient monitoring, follow-up consultations, and more individualized treatment programs. At the same time, regulatory differences between ASEAN countries and limited reimbursement coverage in several markets continue to restrict widespread adoption. Consequently, advanced neurostimulation technologies remain concentrated primarily in large urban hospitals and specialized healthcare facilities.
Manufacturers are responding to changing clinical requirements by developing smaller, lighter, and more portable systems. These developments are attracting interest from outpatient centers, specialist clinics, and dedicated mental health facilities that require greater flexibility in treatment delivery. As a result, assessment and utilization of neurostimulation technologies are expanding across several major ASEAN economies.
Nevertheless, market adoption continues to face challenges related to limited clinician familiarity with advanced neuromodulation protocols. Specialized training is often required for device calibration, patient selection, and treatment planning, while hospitals tend to follow cautious procurement strategies. This is particularly relevant in cost-sensitive public healthcare systems, where purchasing decisions generally prioritize technologies with established clinical outcomes and clear economic value.
Awareness among patients is also improving, particularly in urban centers. Greater exposure to digital mental health services, combined with physician-led education programs in tertiary healthcare networks, is increasing familiarity with non-invasive brain stimulation. Consequently, adjunctive neuromodulation therapies are gradually becoming more accepted within clinical practice across the region.
The ASEAN non-invasive neurostimulation devices market is analyzed based on product type, application, and end user.
Market Segmentation by Product Type
By product type, the market is categorized into transcranial magnetic stimulation devices, transcranial direct current stimulation devices, transcranial ultrasound stimulation devices, and other product types. Transcranial magnetic stimulation devices accounted for the largest share of the market in 2025, supported by their established clinical applications and growing adoption across neurological and psychiatric care.
Market Segmentation by Application
On the basis of application, the market is divided into pain & sensory modulation, functional disorders, cognitive & behavioral regulation, and other applications. Cognitive & behavioral regulation was the leading application segment in 2025, driven by increasing demand for neurostimulation-based approaches in mental health and cognitive-related care.
Market Segmentation by End User
In terms of end user, the market is segmented into hospitals, specialty clinics, ambulatory surgical centers, and other end users. Hospitals held the dominant position in 2025, supported by their access to advanced medical equipment, trained professionals, and a larger pool of patients requiring specialized neurological treatment.
Investment in Neuroscience Research
Non-invasive neurostimulation technologies are increasingly being incorporated into neuroscience research programs across ASEAN. Universities, teaching hospitals, and clinical engineering laboratories are using these systems to investigate brain function and evaluate potential therapeutic applications.
Device manufacturers are increasingly collaborating with academic institutions to refine technology according to regional clinical requirements. These partnerships support prototype development, device testing, and optimization of treatment approaches. Researchers can provide practical feedback that helps manufacturers improve system performance and adapt technologies to local patient and clinical needs.
Hospitals in Southeast Asia are also entering into longer-term evaluation arrangements to assess neurostimulation technologies before committing to broader deployment. Rather than immediately implementing these systems on a large scale, healthcare providers are placing greater emphasis on feedback from physicians and clinical teams. This approach allows manufacturers to identify software limitations, improve user interfaces, and modify device functionality according to real-world requirements.
Growing clinician participation is also influencing research investment priorities. Studies increasingly examine how effectively neurostimulation devices can be integrated into existing rehabilitation and treatment workflows, rather than focusing solely on theoretical technical capabilities. Collaboration between engineers, neurologists, rehabilitation specialists, and other healthcare professionals is helping ensure that device development reflects practical care requirements.
As a result, neurostimulation technologies within ASEAN healthcare facilities are increasingly evolving alongside clinical treatment models, creating a closer connection between medical device innovation and patient-care processes.
Use in Addiction Treatment Therapies
Non-invasive neurostimulation is beginning to attract interest within addiction treatment programs across ASEAN, where it is being explored as an additional component of behavioral and rehabilitation therapies. Rather than depending exclusively on pharmacological approaches, clinicians are investigating stimulation techniques that may influence neural pathways associated with craving management, impulse control, and behavioral regulation.
Urban outpatient clinics are experimenting with structured stimulation sessions that can be coordinated with counseling and behavioral therapy schedules. Such protocol-based approaches are intended to improve treatment participation and encourage continued engagement throughout the recovery process.
The region is also moving toward integrated addiction-care models in which neurostimulation serves as a complementary intervention rather than an independent therapy. Rehabilitation professionals are incorporating stimulation into broader recovery programs that may include counseling, behavioral interventions, and other supportive services.
As these approaches develop, training programs for counselors and clinical staff are increasingly incorporating basic device operation, patient monitoring, and response assessment. This can help community clinics and hospitals safely incorporate neurostimulation into multidisciplinary addiction treatment programs.
Patient experience is also influencing the development of neurostimulation equipment for addiction care. Manufacturers are placing greater emphasis on comfortable device designs, simple interfaces, and easier operation to minimize treatment fatigue. Consistent stimulation schedules may help patients remain engaged with counseling programs and reduce early treatment discontinuation.
These trends are encouraging pilot projects and collaborative treatment networks throughout the region, supporting further investigation of neurostimulation as part of coordinated addiction recovery programs.
The ASEAN non-invasive neurostimulation devices market is demonstrating strong growth, with market size and share analysis reflecting changing healthcare requirements, technology adoption patterns, and competitive developments. The report evaluates key market subsegments across product type, application, and end user and assesses their contribution to overall market performance.
Transcranial magnetic stimulation devices represented the largest product type segment in 2025. Their leadership was supported by established clinical effectiveness, expanding use in neurological and psychiatric disorders, and greater availability across healthcare facilities.
Cognitive & behavioral regulation accounted for the largest application share in 2025. Growth in this segment is associated with increasing mental health concerns and the expanding use of neurostimulation for depression, anxiety, and cognitive enhancement.
Hospitals were the leading end-user segment in 2025, supported by their access to advanced neurostimulation technologies, qualified medical professionals, and growing numbers of patients requiring specialized neurological services.
Scope of the ASEAN Market Report
The ASEAN Non-Invasive Neurostimulation Devices Market Size and Forecast (2022–2033) report provides a comprehensive evaluation of the market and covers the following areas:
Market segments included within the study
Market dynamics, including drivers, restraints, opportunities, and emerging trends
Market concentration and heat map analysis
Leading companies and recent developments
Detailed company profiles
SWOT analysis of key market participants
The geographical scope of the ASEAN non-invasive neurostimulation devices market covers Indonesia, Malaysia, the Philippines, Singapore, Thailand, and Vietnam. Indonesia accounted for the largest market share in 2025.
Country-Level Market Analysis
Indonesia leads the ASEAN non-invasive neurostimulation devices market, supported by its large population base, increasing prevalence of neurological and psychiatric conditions, expanding urban hospital infrastructure, and rising private healthcare investment. These factors are contributing to greater adoption of advanced technologies for neurorehabilitation and pain management.
Malaysia is experiencing steady market development due to its advanced hospital infrastructure and increasing availability of neuromodulation therapies within specialist clinics. Its healthcare system is also gradually adopting innovative treatment approaches for chronic pain and mood-related disorders.
The Philippines represents a growing opportunity because of its significant need for improved neurological healthcare services and geographical characteristics that can increase the value of portable treatment technologies. Rising healthcare expenditure in urban areas, supported in part by the expansion of the middle class, is also encouraging investment in specialized medical services.
Singapore is one of the region's most advanced markets for healthcare innovation. Strong biomedical research capabilities, participation in clinical trials, sophisticated healthcare infrastructure, and a technology-oriented healthcare environment have enabled the country to integrate neurotechnology into clinical practice relatively quickly.
Thailand benefits from its well-established medical tourism industry and continued development of rehabilitation services for stroke and spinal conditions. Public healthcare programs addressing the needs of an aging population are also contributing to demand for neurological and rehabilitation technologies.
Vietnam is emerging as a rapidly developing market as healthcare infrastructure is modernized, private hospital networks expand, and awareness of non-invasive brain stimulation increases. However, treatment affordability remains an important consideration, while insurance coverage for newer technologies is developing gradually.
Overall, adoption rates vary across ASEAN according to healthcare infrastructure, clinical expertise, reimbursement availability, and affordability in both public and private healthcare settings. Digital health solutions and cross-border collaboration can improve access to advanced medical technologies while supporting clinician training and knowledge exchange.
Greater regulatory alignment across ASEAN could further encourage private investment and simplify the introduction of new neurostimulation technologies. Over time, these developments may accelerate adoption across hospitals, rehabilitation facilities, specialist clinics, and other healthcare environments.
Report Structureand Coverage
The report provides qualitative and quantitative analysis of the ASEAN non-invasive neurostimulation devices market across product type, application, end user, and geography. Chapter 2 presents the key findings, major trends, and market outlook for the ASEAN region. Chapter 3 explains the research methodology, while Chapter 4 provides an ecosystem analysis.
Chapter 5 examines the major industry dynamics, including market drivers, restraints, opportunities, and emerging trends. It also assesses the potential impact of these factors on market growth. Chapter 6 evaluates historical market revenues and provides forecasts through 2033.
Chapters 7 through 10 analyze the ASEAN market according to product type, application, end user, and geography. Geographic coverage includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, and Vietnam. These chapters provide market revenue assessments, forecasts, and an analysis of the factors influencing market development.
Chapter 11 presents competitive analysis and heat map analysis of key companies operating in the market. Chapter 12 examines the industry landscape, including strategic initiatives, new product or business developments, mergers, joint ventures, and other competitive activities.
Chapter 13 provides detailed profiles of major companies operating in the ASEAN market. These profiles cover company information, business descriptions, product portfolios, financial overviews, SWOT analysis, and significant developments. Chapter 14 serves as the appendix and includes a brief company overview, abbreviations, and relevant disclaimers.
Research Methodologyand Recent Developments
The ASEAN non-invasive neurostimulation devices market has been assessed using qualitative and quantitative information obtained through primary and secondary research. The study incorporates information from corporate publications, industry associations, specialized databases, company reports, investor presentations, and other relevant sources.
Several notable developments have contributed to the evolution of the regional market:
In August 2023, BrainsWay Ltd. announced an expansion in the availability of its Deep TMS non-invasive brain stimulation systems in Taiwan through additional installations. The initiative strengthened the company's presence in the broader Asia Pacific region and supported access to neuropsychiatric care technologies.
In February 2023, Nexstim Plc announced that it had received an order from Hong Kong through distributor Ampere Medical for its NBS 5 navigated transcranial magnetic stimulation (nTMS) system. The system supports neuroscience research and brain-mapping applications using non-invasive neurostimulation technology.
Table of Contents
125 Pages
- 1. Introduction
- 1.1 Business Market Insights Research Report Guidance
- 1.2 Market Segmentation
- 2. Executive Summary
- 2.1 Key Market Insights
- 3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
- 4. ASEAN Non-Invasive Neurostimulation Devices Market Landscape
- 4.1 Overview
- 4.2 Ecosystem Analysis
- 4.2.1 List of Vendors in the Value Chain
- 5. ASEAN Non-Invasive Neurostimulation Devices Market - Key Market Dynamics
- 5.1 Market Drivers
- 5.2 Market Restraints
- 5.3 Market Opportunities
- 5.4 Future Trends
- 5.5 Impact of Drivers and Restraints
- 6. ASEAN Non-Invasive Neurostimulation Devices Market - Analysis
- 6.1 ASEAN Non-Invasive Neurostimulation Devices Market Revenue 2022-2033 (US$ Million)
- 6.2 ASEAN Non-Invasive Neurostimulation Devices Market Forecast Analysis
- 7. ASEAN Non-Invasive Neurostimulation Devices Market Analysis - by Product Type
- 7.1 Transcranial Magnetic Stimulation Devices
- 7.1.1 Overview
- 7.1.2 Transcranial Magnetic Stimulation Devices: ASEAN Non-Invasive Neurostimulation Devices Market - Revenue and Forecast, 2022-2033 (US$ Million)
- 7.2 Transcranial Direct Current Stimulation Devices
- 7.2.1 Overview
- 7.2.2 Transcranial Direct Current Stimulation Devices: ASEAN Non-Invasive Neurostimulation Devices Market - Revenue and Forecast, 2022-2033 (US$ Million)
- 7.3 Transcranial Ultrasound Stimulation Devices
- 7.3.1 Overview
- 7.3.2 Transcranial Ultrasound Stimulation Devices: ASEAN Non-Invasive Neurostimulation Devices Market - Revenue and Forecast, 2022-2033 (US$ Million)
- 7.4 Other Product Types
- 7.4.1 Overview
- 7.4.2 Other Product Types: ASEAN Non-Invasive Neurostimulation Devices Market - Revenue and Forecast, 2022-2033 (US$ Million)
- 8. ASEAN Non-Invasive Neurostimulation Devices Market Analysis - by Application
- 8.1 Pain & Sensory Modulation
- 8.1.1 Overview
- 8.1.2 Pain & Sensory Modulation: ASEAN Non-Invasive Neurostimulation Devices Market - Revenue and Forecast, 2022-2033 (US$ Million)
- 8.2 Functional Disorders
- 8.2.1 Overview
- 8.2.2 Functional Disorders: ASEAN Non-Invasive Neurostimulation Devices Market - Revenue and Forecast, 2022-2033 (US$ Million)
- 8.3 Cognitive & Behavioral Regulation
- 8.3.1 Overview
- 8.3.2 Cognitive & Behavioral Regulation: ASEAN Non-Invasive Neurostimulation Devices Market - Revenue and Forecast, 2022-2033 (US$ Million)
- 8.4 Other Applications
- 8.4.1 Overview
- 8.4.2 Other Applications: ASEAN Non-Invasive Neurostimulation Devices Market - Revenue and Forecast, 2022-2033 (US$ Million)
- 9. ASEAN Non-Invasive Neurostimulation Devices Market Analysis - by End User
- 9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: ASEAN Non-Invasive Neurostimulation Devices Market - Revenue and Forecast, 2022-2033 (US$ Million)
- 9.2 Specialty Clinics
- 9.2.1 Overview
- 9.2.2 Specialty Clinics: ASEAN Non-Invasive Neurostimulation Devices Market - Revenue and Forecast, 2022-2033 (US$ Million)
- 9.3 Ambulatory Surgical Centers
- 9.3.1 Overview
- 9.3.2 Ambulatory Surgical Centers: ASEAN Non-Invasive Neurostimulation Devices Market - Revenue and Forecast, 2022-2033 (US$ Million)
- 9.4 Other End Users
- 9.4.1 Overview
- 9.4.2 Other End Users: ASEAN Non-Invasive Neurostimulation Devices Market - Revenue and Forecast, 2022-2033 (US$ Million)
- 10. ASEAN Non-Invasive Neurostimulation Devices Market - Analysis
- 10.1 ASEAN
- 10.1.1 ASEAN Non-Invasive Neurostimulation Devices Market - Share (%) - by Country
- 10.1.1.1 ASEAN Non-Invasive Neurostimulation Devices Market - Revenue and Forecast Analysis - by Country
- 10.1.1.1 Indonesia: ASEAN Non-Invasive Neurostimulation Devices Market - Revenue and Forecast, 2022-2033 (US$ Million)
- 10.1.1.1.1 Indonesia: ASEAN Non-Invasive Neurostimulation Devices Market Breakdown, by Product Type
- 10.1.1.1.2 Indonesia: ASEAN Non-Invasive Neurostimulation Devices Market Breakdown, by Application
- 10.1.1.1.3 Indonesia: ASEAN Non-Invasive Neurostimulation Devices Market Breakdown, by End User
- 10.1.1.2 Malaysia: ASEAN Non-Invasive Neurostimulation Devices Market - Revenue and Forecast, 2022-2033 (US$ Million)
- 10.1.1.2.1 Malaysia: ASEAN Non-Invasive Neurostimulation Devices Market Breakdown, by Product Type
- 10.1.1.2.2 Malaysia: ASEAN Non-Invasive Neurostimulation Devices Market Breakdown, by Application
- 10.1.1.2.3 Malaysia: ASEAN Non-Invasive Neurostimulation Devices Market Breakdown, by End User
- 10.1.1.3 Philippines: ASEAN Non-Invasive Neurostimulation Devices Market - Revenue and Forecast, 2022-2033 (US$ Million)
- 10.1.1.3.1 Philippines: ASEAN Non-Invasive Neurostimulation Devices Market Breakdown, by Product Type
- 10.1.1.3.2 Philippines: ASEAN Non-Invasive Neurostimulation Devices Market Breakdown, by Application
- 10.1.1.3.3 Philippines: ASEAN Non-Invasive Neurostimulation Devices Market Breakdown, by End User
- 10.1.1.4 Singapore: ASEAN Non-Invasive Neurostimulation Devices Market - Revenue and Forecast, 2022-2033 (US$ Million)
- 10.1.1.4.1 Singapore: ASEAN Non-Invasive Neurostimulation Devices Market Breakdown, by Product Type
- 10.1.1.4.2 Singapore: ASEAN Non-Invasive Neurostimulation Devices Market Breakdown, by Application
- 10.1.1.4.3 Singapore: ASEAN Non-Invasive Neurostimulation Devices Market Breakdown, by End User
- 10.1.1.5 Thailand: ASEAN Non-Invasive Neurostimulation Devices Market - Revenue and Forecast, 2022-2033 (US$ Million)
- 10.1.1.5.1 Thailand: ASEAN Non-Invasive Neurostimulation Devices Market Breakdown, by Product Type
- 10.1.1.5.2 Thailand: ASEAN Non-Invasive Neurostimulation Devices Market Breakdown, by Application
- 10.1.1.5.3 Thailand: ASEAN Non-Invasive Neurostimulation Devices Market Breakdown, by End User
- 10.1.1.6 Vietnam: ASEAN Non-Invasive Neurostimulation Devices Market - Revenue and Forecast, 2022-2033 (US$ Million)
- 10.1.1.6.1 Vietnam: ASEAN Non-Invasive Neurostimulation Devices Market Breakdown, by Product Type
- 10.1.1.6.2 Vietnam: ASEAN Non-Invasive Neurostimulation Devices Market Breakdown, by Application
- 10.1.1.6.3 Vietnam: ASEAN Non-Invasive Neurostimulation Devices Market Breakdown, by End User
- 11. Competitive Landscape
- 11.1 Heat Map Analysis by Key Players
- 11.2 Company Positioning and Concentration
- 12. Industry Landscape
- 12.1 Overview
- 12.2 Market Initiative
- 12.3 Partnerships and Collaborations
- 12.4 Other Developments
- 13. Company Profiles
- 13.1 ONWARD Medical N.V.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
- 13.2 eNeura Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
- 13.3 Neuronetics
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
- 13.4 BrainsWay Ltd.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
- 13.5 Soterix Medical Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
- 13.6 Flow Neuroscience
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
- 13.7 Magstim
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
- 13.8 Nexstim
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
- 13.9 Neurosoft
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
- 13.10 Remed
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
- 14. Appendix
- 14.1 About Business Market Insights
- 14.2 List of Abbreviations
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
